Given the interactions between MAPK signaling and ERα in ovarian cancer, we hypothesized that deregulation of MAPK modulates the intrinsic activity of ERα, and contributes to endocrine resistance in EOC. The gene discussed is ESR1; the disease is ovarian cancer.